Gilead Acquires Investigational HIV Vaccine From Spanish Biotech Aelix
(PFE) - Analyzing Pfizer's Short Interest
S&P 500, Dow Hit Records Right After Open | Live Stock
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Price Over Earnings Overview: Gilead Sciences
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
ひな☆彡 SOXL(Bull) : I see it slightly differently. It might pull back a little before blasting off
MonkeyGee OP ひな☆彡 SOXL(Bull) : That could happen also. No one knows except the men in black.
ひな☆彡 SOXL(Bull) MonkeyGee OP : True true, but yeah I think it will spike sometime soon
ひな☆彡 SOXL(Bull) : I usually get long call option which has long expiry date, if I think I missed the dip. This can be one of them
MonkeyGee OP ひな☆彡 SOXL(Bull) : yes, i do the same. PFE has been a none mover, but maybe under new management, this will have some life now.